Are you interested in joining the ToxMSDT program?
Applications for 2022-2023 will open February 1 and close April 1, 2022. Program participants will be notified of acceptance to the program by June 1, 2022.
- STEM major
- Minimum cumulative GPA of 3.0
- At least a second-year undergraduate student
- Completion of at least one semester of general biology and general chemistry
- Enrolled in an accredited undergraduate institution at the time of application, with continuing enrollment for the next academic year concurrent with the ToxMSDT program
- Member of a group underserved in the biomedical sciences (for example, underrepresented racial/ethnic groups; those from disadvantaged backgrounds such as low socioeconomic status, or grew up in a rural or inner-city setting; NIH notice).
- US citizen or US permanent resident
- Complete the Student Application.
- Upload unofficial undergraduate transcripts, including all coursework and current enrollment, with the application
- Send the Reference Form to a faculty who knows your academic performance well.
Meet the 2017-2018 Mentees
Fifteen undergraduate student mentees from historically underrepresented ethnic/racial backgrounds were recruited into the program in the spring and summer of 2017. Student mentees were recruited from Iowa State University, Tuskegee University, Georgia Southern University, Agnes Scott College, and Florida International University. Students are sophomores, juniors and seniors enrolled in STEM majors. The candidates are meritorious students with a GPA of at least 3.0 or higher. Students applied competitively to enter the program. The best candidates were selected and matched to a mentor who is an established toxicologist in academia or industry.
Benefits to mentees:
Benefits to mentees:
- Knowledge and skills gained through this year-long program will position mentees to compete effectively for graduate school training positions
- Mentees will gain a supportive network of mentors and fellow mentees
- Knowledge gained through this program will apply to the broader biomedical, behavioral, and clinical research enterprise, all relevant to NIH